EI
LJPC

Ellevest Inc’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Ellevest Inc’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41
Closed – – 1489
2021
Q1 		$0 Hold
41
– – ﹤0.01% 1409
2020
Q4 		$0 Buy
+41
New +$175 ﹤0.01% 1456
2020
Q2 		– Sell
-197
Closed -$1K – 1468
2020
Q1 		$1K Buy
197
+3
+2% +$19 ﹤0.01% 1062
2019
Q4 		$1K Buy
+194
New +$1.15K ﹤0.01% 947

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ellevest Inc's LJPC Position: Q2 2021 in Review

Ellevest Inc sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 41 shares.

Ellevest Inc first reported a position in LJPC in Q4 2019 and held it in 4 quarters. The position peaked at $1K in Q1 2020. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Ellevest Inc reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Ellevest Inc sold 41 La Jolla Pharmaceutical Company shares in Q2 2021.
  • Ellevest Inc first reported a position in La Jolla Pharmaceutical Company in Q4 2019 and held it in 4 quarters.
  • Ellevest Inc's La Jolla Pharmaceutical Company position peaked at $1K in Q1 2020.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Ellevest Inc's 13F filing for Q2 2021, filed 13 Jul 2021.